Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study

Yidong Huang,Zhi Zheng,Rui Xu,Haiqiao Zhang,Jie Yin,Xiaoye Liu,Jun Zhang,Guangyong Chen,Zhongtao Zhang
DOI: https://doi.org/10.1097/md.0000000000037289
IF: 1.6
2024-03-13
Medicine
Abstract:Adenocarcinoma of esophagogastric junction (AEG) is a type of adenocarcinoma lesion that originates from the glandular epithelium of the gastrointestinal tract and invades esophagogastric junction. [ 1 ] In recent years, the incidence and mortality of AEG have increased. [ 2–4 ] This region is a special anatomical location, involving complex operation and multiple lymphatic drainage approaches. [ 5 ] The drainage boundary and dissection extends from the lymph nodes around the stomach and it is localized around the cardia for multiple groups of lymph nodes. [ 6 ] As a result, AEG can be treated with diverse surgical methods and exhibits a worse prognosis compared with common gastric cancer. [ 7 , 8 ] Previous studies have shown that mediastinal lymph node metastasis (LNM) accounts for 10% to 20% of all lymphatic metastasis in AEG. [ 9–11 ] However, other studies reported that the mediastinal LNM rate was low. [ 12 , 13 ] Therefore, it is urgent to confirm whether the mediastinal lymph node dissection (LND) of the lymph node drainage areas is required in Siewert II/III AEG in order to improve the curative effect of radical operation and prognosis. The present study attempted to analyze the risk factors of LNM and the follow-up survival data in patients with Siewert II/III AEG in order to provide more accurate treatments for AEG patients with different clinicopathological features.
medicine, general & internal
What problem does this paper attempt to address?